Related Experiment Video
Updated: Jul 14, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
Published on: January 18, 2021
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Samuli Kangaslampi1,2, Josjan Zijlmans3,4
1Faculty of Social Sciences/Psychology, Tampere University, Tampere, Finland. samuli.kangaslampi@tuni.fi.
3,4-Methylenedioxymetamphetamine (MDMA)-assisted psychotherapy shows promise for adolescent posttraumatic stress disorder (PTSD). Research suggests adapting MDMA-AP for youth could improve outcomes, but clinical trials are needed to ensure safety and efficacy.
Area of Science:
- Psychiatry
- Psychopharmacology
- Adolescent Mental Health
Background:
- Posttraumatic stress disorder (PTSD) affects many adolescents, with current treatments having limitations.
- 3,4-Methylenedioxymetamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a potential new treatment for adult PTSD.
- There is a need to explore effective PTSD treatments for adolescents.
Purpose of the Study:
- To present a rationale for using MDMA-assisted psychotherapy (MDMA-AP) to treat PTSD in adolescents.
- To suggest adaptations of MDMA-AP for adolescent populations.
- To discuss potential risks and ethical considerations of MDMA-AP in adolescents.
Main Methods:
- Review of existing evidence on MDMA's effects as an adjunct to therapy.
- Proposal of specific adaptations for MDMA-AP in adolescents based on trauma-focused treatments.
- Discussion of potential risks, including side effects, toxicity, misuse, and ethical concerns.
Main Results:
- MDMA may facilitate trauma processing, enhance therapeutic alliance, and improve extinction learning.
- Proposed adaptations include reinforcing motivation, strengthening the therapeutic alliance, emotion management, directive exposure, integration support, and family involvement.
- Potential risks specific to adolescents require careful consideration.
Conclusions:
- MDMA-assisted psychotherapy (MDMA-AP) shows potential for treating PTSD in adolescents.
- Adaptations are necessary to tailor MDMA-AP for this age group.
- Clinical trials are essential to establish the safety and efficacy of MDMA-AP for adolescent PTSD, rather than off-label use or extrapolation from adult data.
Related Concept Videos
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Interpersonal Psychotherapy
Psychodynamic Therapy
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Group Therapy

